Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressing Autologous T Cells as an Immunotherapy for Children With Solid Tumors (CARE)
NCT04715191 · RECRUITING · Phase 1
ReadTheTrial indexes 1 studies for Liver Cancer. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Liver Cancer.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
There are 1 clinical trials listed for Liver Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Liver Cancer trials are distributed across: Phase 1 (1).